http://articles.mercola.com/sites/articles/archive/2001/02/10/cancidas.aspxUS regulators have approved Merck & Co.'s new drug Cancidas (caspofungin acetate), the first of a new class of drugs designed to fight potentially deadly fungal infections . The US Food and Drug Administration approved the drug for treatment of invasiveenCommunityServer 2008.5 SP1 (Build: 31106.3070)